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Left ventricular cineangiograms performed at the time
of diagnosis in 88 patients with hypertrophic cardio-
myopathy were digitized to evaluate the relation of left
ventricular function and prognosis in hypertrophic car-
diomyopathy. Eleven patients died suddenly after a mean
follow-up period of 7.5 ± 7 years, 10 patients died of
congestive heart failure or after cardiac surgery and 67
were alive after a mean follow-up period of 8.6 ± 4
years. Measurements of left ventricular volume, ejection
fraction, peak rate of ejection and filling and time to
peak rate of ejection and fillingwere derived from curves
of ventricular volume and its rate of change during the
cardiac cycle. Patients who died suddenly had a lower
peak rate of ventricular ejection (stroke volume-nor-
malized peak ejection rate 5.41 ± 0.69 versus 6.24 ±
1.33 S-I; P = 0.006) and lower peak rate of ventricular
filling (end-diastolic volume-normalized peak filling rate
4.02 ± 0.94 versus 4.88 ± 1.53 S-I; P = 0.02) and
stroke volume-normalized peak filling rate (4.75 ± 1.08
versus 5.82 ± 1.70 S-I; P = 0.01) compared with sur-
vivors. Stepwise regression analysis revealed that sudden
death was best predicted by the combination of increased
end-diastolic volume, small end-systolic volume and low
peak filling rate (predictive accuracy 32%, false negative
18% and false positive 28%). The addition of clinical
features and hemodynamic measurements to the analysis
improved predictive accuracy to 43% (false negative 18%
and false positive 18%).
The natural history of hypertrophic cardiomyopathy is char-
acterized by a slow progression of symptoms (1-6), but the
clinical course may be complicated by ventricular arrhyth-
mias and sudden death (7-10). A clinical profile of patients
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Ambulatory electrocardiographic monitoring per-
formed in 57 of the 88 patients I month to 17 years
(median 8 years) after diagnosis revealed ventricular
tachycardia in 14 (25%). Of these, 10 who survived had
hyperkinetic systolic function at diagnosis, whereas the
4 who died suddenly had impaired systolic function (end-
diastolic volume-normalized peak ejection rate 5.93 ±
1.2 versus 4.01 ± 1.2 S-I, respectively; p = 0.04). In
hypertrophic cardiomyopathy, ventricular tachycardia
is a sensitive but nonspecific marker of adults who are
at risk of sudden death. Impaired systolic function may
be an important determinant of which patients with ven-
tricular tachycardia die suddenly.
This study shows that indexes of ventricular function
contribute to the identification of patients at particular
risk of sudden death. However, the predictive power of
the clinical features and hemodynamic and angiographic
measurements that could be assessed was poor. To ac-
curately identify the patient at high risk ofsudden death,
further studies are needed which incorporate into the
analysis measurements of right and left ventricular hy-
pertrophy, the characterization of gradients in relation
to mechanism and assessment of the capacity of the myo-
cardium to propagate as well as initiate arrhythmia.
(J Am Coli Cardiol1985;5:1064-74)
at greatest risk of sudden death has been developed; young
age at diagnosis, syncope, family history of sudden death
and ventricular tachycardia have been associated with poor
prognosis (8-10). Hemodynamic measurements have not
been helpful in identifying patients at particular risk (9, II ,12),
and the relation of other measurements of left ventricular
function to survival has not been evaluated. In this study,
ventricular volumes and their rates of change during the
cardiac cycle were derived from digitized cineangiograms
and were analyzed to determine the relation of indexes of
left ventricular function to outcome, in particular to the
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development of ventricular tachycardia and sudden death in
patients with hypertrophic cardiomyopathy.
Methods
Patients. We reviewed left ventricular cineangiograms
performed at diagnosis in 228 patients with hypertrophic
cardiomyopathy. The clinical course of these patients has
been previously reported (9); angiograms of 88 were tech-
nically suitable for digitization. The diagnosis of hyper-
trophic cardiomyopathy was made on typical clinical. hemo-
dynamic and angiographic criteria (13). There were 52 men
and 36 women aged 7 to 66 years (mean 37). At diagnosis,
51 (58%) had mild and 9 (10%) had moderate or severe
dyspnea, 42 (48%) had chest pain, 22 (25%) experienced
syncopal episodes and 12 (14%) were asymptomatic. Nine
patients (10%) had a family history of hypertrophic cardio-
myopathy and sudden death. The electrocardiogram re-
corded at diagnosis showed atrial fibrillation in 4 patients;
left or right atrial enlargement ( 14) was present in 41 (47%)
and 60 (68%) had voltage criteria of left or right ventricular
hypertrophy, or both (15).
Follow-up. During a follow-up period of 2 to 23 years
(mean 8),21 patients died, II suddenly (16) and 10 of other
cardiac causes (4 of cardiac failure and 6 in the perioperative
period after myotomy/myectomy). Of the patients who died
suddenly, five were young (aged 8 to 29 years), were asymp-
tomatic and had a short duration of follow-up (mean 4 ±
3 years) and six were older (aged 40 to 66 years), had
moderate or severe symptoms and had been followed up for
a mean of 10 years. Patients who died suddenly and sur-
vivors had similar duration of follow-up study (7.5 ± 7
and 8.6 ± 4 years, respectively, p = NS), a similar in-
cidence of adverse family history (10% and 9%) and at least
one syncopal episode (27% and 25%). Twenty-one patients
(24%) had progressive symptoms of dyspnea or chest pain
during follow-up study. All four patients who were in es-
tablished atrial fibrillation at diagnosis died, one suddenly.
An additional six developed atrial fibrillation during follow-
up study; of these, two developed ventricular tachycardia
and two died suddenly. Voltage criteria of left ventricular
hypertrophy (15) were present in 91% of patients who died
suddenly and in 66% of survivors. During follow-up study,
medications included beta-adrenergic blocking drugs in 67
(76%), digoxin in 16 (18%), diuretic drugs in 20 (23%) and
verapamil in 8 (9%). Eighteen patients (20%) received a
class I antiarrhythmic agent for a maximum of 3 years and
none was taking amiodarone during the period of analysis.
Ambulatory electrocardiographic monitoring. Am-
bulatory electrocardiographic monitoring (for I to 10 days;
mean 3) was performed 1 month to 17 years (median 8
years) after diagnosis in 57 patients receiving no treatment
other than beta-adrenergic blocking agents, verapamil or di-
goxin. These patients are part of a larger group that has
been previously reported (8). In brief, 4 of 14 patients with
ventricular tachycardia (29%) died suddenly during treat-
ment with disopyramide, quinidine sulfate or mexiletine,
either alone or in combination with propranolol.
Angiographic indexes of left ventricular function were
compared: I) in survivors and patients who died suddenly
and in those who died of other cardiac causes, 2) in patients
with and without progressive symptoms, and 3) in those
with and without ventricular tachycardia. These indexes
were entered into a stepwise regression analysis to determine
their value for predicting sudden death, progressive symp-
toms and ventricular tachycardia.
Cardiac catheterization. Cardiac catheterization was
performed with patients fasting and after premedication with
diazepam. Four patients were receiving digoxin for control
of atrial fibrillation and two were taking propranolol. The
others received no cardioactive medications for at least 72
hours before angiography. The mean pulmonary capillary
wedge and left ventricular end-diastolic pressures were 16
± 6 and 18 ± 7 mm Hg, respectively. A left ventricular
gradient of 20 mm Hg or more was recorded at rest in 32
patients and after provocation (at first with isoproterenol
infusion, later with amyl nitrate inhalation and the Valsalva
maneuver) in an additional 20 patients.
After baseline hemodynamic measurements, left ventricu-
lography was performed in the right anterior oblique pro-
jection during the injection of 35 to 50 cc of sodium and
meglumine diatrizoate (Urografin) into the left ventricular
cavity for 3 to 5 seconds. Cine films were recorded at 48
frames/so Calibration was performed using a grid at mid
Systolic Frames Diastolic Frames
Figure 1. Superimposed left ventricular cavity
contours during systole (left) and diastole (right)
derived by frame by frame digitizationof a cardiac
cycle from the left ventricular cineangiogram of a
patient with hypertrophic cardiomyopathy.
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SV (cc) = EDV - ESV
Ef' (%-) = SV/EDV x 100 ,
Digitization. The cineangiograms were digitized by the
same investigator using a Summagraphics digitizing table
interfaced with a Prime 750 computer. Measurements were
made on complete cardi ac cycles, omitting premature beats
and beats immediately after a prem ature beat. Successive
frame s of each selected cardiac cycle were projected onto
a digitizing table and the contours of the left ventricular
cavity were traced using a cursor (Fig. I); strings of 50 to
100 coordinates were generated per frame. Left ventricular
cavity area was deri ved by numer ical integrati on : cavi ty
volume was est imated using an area-length formul a based
on an ellipsoid model for the left ventricle (17). Volume-
time curves were generated for each digitized cardiac cycle.
Curve smoothing was performed by passing a second degre e
polynomial through nine consecutive volume points (18,19).
End-systole and end-diastole were identified as point s of
minimal and maximal volume, respectively.
Stroke volume (SV) and ejec tion f raction (EF) were
calculated:
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Figure 2. A, Plot of left ventricular (LV) cavity volume during
the cardiac cycle derived from digitized cineangiogram of a patient
with hypertrophic cardiomyopathy. B, Plot of the rate of change
of left ventricular volume during the cardiac cycle in the same
patient. The greatest negativedeflection (peak ejection rate [PER])
occurred at 0.15 second (time to peakejection rate [TPER]), whereas
the greatest positive deflection (peak filling rate IPFRJ) occurred
at 0.23 second after end-systole (time to peak filling rate [TPFRJ) .
ESV = end-systolic volume; TD = duration of diastole; TS =
duration of systole.
chest level. Mitral regurgitation was mild in 21 patients and
moderate in 4 patients. Coron ary arteriography was per-
formed in 16 patients with severe or refractory chest pain;
none had significant steno ses of epicardial coronary vessel s.
where EDV = end-diastolic volume and ESV = end-sys-
tolic volume.
Continuous plots were generated of the rates of volume
change using the instantaneous first derivative of the vol-
ume-tim e curve. Peak ejecti on rate was defined as the peak
negative point of the first derivative volume curve in systole
and peak filling rate as the peak positive point in diastole
(Fig . 2). Peak ejection and filling rate were normal ized by
two methods: division by end-dias tolic volume and by stroke
volume. Time to peak ejec tion rate was measured from the
beginn ing of the cardiac cycle and was also expressed as a
proportion of total systole (systolic index); time to peak
filling rate was measured from end-systole.
The selected cardiac cycle was digitized twice in all pa-
Table 1. Reproducibility of Angiographic Estimates of Left Ventricular Volumes. Peak Ejection
and Filling Rates and Time Intervals: Comparison of Unsmoothed and Smoothed Analyses
Mean Percent Differences Between Repeat Determinations
Same Beat Different Beat
Unsmoothed (\) Smoothed (2) (I) - (2) Unsmoothed ( I) Smoothed (2) ( I) - (2)
(mean) (mean) (mean:!: SEM) (mean) (mean) (mean e; SEM)
ESV 10. 1 6. 1 4.0 :!: 1.1" 25.5 29.3 -3.8 :!: 5.1
EDV 4.1 3.5 0.6 :!: 0.2" 7.6 8.0 - 0.4 :!: 0.4
PER 9.6 7.0 2.6 :!: 0.9" 15.6 12.1 3.5 :!: 1.1
PFR 7.7 5.7 2.0 :!: 0.7" 13.5 12.6 0.9 :!: 1.1
TS 3.8 3.0 0.8 :!: 0.5 4.4 11.0 - 6.5 :!: 2.3
TO 3.3 3. 1 0.2 :!: 0.5 6.0 10.7 - 4.6 :!: 2.4
TPER 10.4 9.5 0.9 :!: 2.5 10.0 8.1 1.9 :t 1.6
TPFR 2.8 2.6 0.2 :!: 0.6 5.2 5.4 - 0 .2 :!: 0.7
"p < 0 .01 . EDV end-diastolic volume; ESV end-systolic volume; PER = peak ejection rate;
PFR = peak filling rate ; TO = duration of diastole; TPER = time to peak ejection rate; TPFR = time to
peak filling rate ; TS = duration of systole.
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Variable
A. Clinical Data at Diagnosis
Definition
Sex
Age at onset of symptoms
Age at diagnosis
Family history
Symptoms at diagnosis
Dyspnea
Exertional chest pain
Syncope
Rhythm
P waves
PR interval
Axis
Ventricular conduction
S wave in VI i R wave in V, amplitude
R wave in aVL amplitude
Ventricular hypertrophy
Female: male
I to SI{ years
7 to 66 years
None: HC: HC and sudden death
Absent: present
None: mild; moderate or severe
No: yes
No; yes
B. ECG at Diagnosis
Sinus: atrial fibrillation
Normal; atrial enlargement: NA
Normal; abnormal; NA
Normal; right: left
Normal or partial RBBB or partial LBBB: RBBB: LBBB
12to<}2 mm
o to 2') mm
None: RVH: LVH or BVH
C. Hemodynamic Measurements at Diagnosis
Right atrial pressure (mean)
Pulmonary capillary wedge pressure (mean)
LVend-diastolic pressure
LV outflow gradient (20 rrn Hg)
LV outflow gradient (without provocation)
Mitral regurgitation
Duration of follow-up study from diagnosis
Change in symptoms up to last visit
Development of atrial fibrillation
Development of ventricular tachycardia
4 to II{ mm Hg, or NA
6 to 35 mm Hg. or NA
7 to 40 mm Hg. or NA
No: yes
oto ISO mm Hg
None: mild: moderate or severe
D. Follow-up Study
I to 23 years
None or improved: worse
No; yes
No: yes; NA
BVH = biventricular hypertrophy: ECG = electrocardiogram: HC = hypertrophic cardiomyopathy;
LBBB = left bundle branch block: LVH = left ventricular hypertrophy: NA = not available or not applicable:
RBBB = right bundle branch block; RVH = right ventricular hypertrophy.
tients to assess the reproducibility of the measurements.
Within-beat reproducibility was expressed as the mean per-
cent difference between the repeat measurements of each
cycle. An additional cycle was digitized in 37 patients. and
beat to beat reproducibility was expressed as the mean per-
cent difference between that cycle and averaged measure-
ments of the initial cycle (Table l ). Curve smoothing im-
proved the reproducibility of ventricular volumes and their
rates of change and was, therefore. performed for these
analyses. Time intervals were estimated from unsmoothed
curves because smoothing did not improve reproducibility
and occasionally resulted in considerable changes in time
intervals.
Control group. A second group of 13 control subjects
without demonstrable heart disease (9 men and 4 women)
aged 17 to 58 years (mean 38) were analyzed for compar-
ison. They were investigated because of chest pain. All had
their cardioactive medications withheld for at least 72 hours
before cardiac catheterization and left ventriculography. None
had clinical, electrocardiographic. hemodynamic or angio-
graphic abnormalities detected. The results in these subjects
were used to define normal limits for the measurements.
Statistical analysis. The paired t test was used to assess
differences between unsmoothed and smoothed data. The
unpaired t test or two sample Wilcoxon test was used 'for
quantitative comparison of angiographic measurements. The
chi-square test was used for comparison of clinical data. A
stepwise regression analysis was performed using Ii on-
giographic indexes of left ventricular function and 25 clin-
ical, electrocardiographic and hemodynamic variables (Ta-
ble 2) to predict sudden death. progressive symptoms arid
development of ventricular tachycardia. The influence of
abnormalities during electrocardiographic monitoring on the
development of progressive symptoms and sudden death
could not be assessed as these recordings were performed
long after the time of diagnosis. Logarithmic transformation
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Table 3. Comparison of Measurements of Left Ventricular Volumes, Peak Ejection and Filling
Rates and Time Intervals in Patients With Hypertrophic Cardiomyopathy and in Control Subjects
Hypertrophic Cardiomyopathy (n = 88) Control Subjects (n = 13)
EDV (cc) 138 ± 49 149 ± 45
ESV (cc) 24 ± 18* 35 ± 13
SV (cc) 115 ± 43 114 ± 39
EF (%) 83 ± 10* 76 ± 7
PER (cc/s) 688 ± 264 644 ± 205
PERlEDV (liters/s) 5.06 ± 1.17* 4 .36 ± 0.66
PERlSV (liters/s) 6.11 ± 1.33 5.74 ± 0.77
PFR (cc/s) 707 ± 266 713 ± 286
PFRlEDV (liters/s) 4.86 ± 1.60 4 .37 ± 0 .78
PFRl5V (liters/s) 5.76 ± 1.75 5.66 ± 1.08
TS (ms) 295 ± 55 267 ± 54
TPER (ms) 148 ± 64 123 ± 44
51 (% ) 49 ± 17 46 ± 15
TD (rns) 469 ± 156 401 ± 116
TPFR (ms) 185 ± 53* 118 ± 32
*p < 0.01. EDV = end-diastolic volume; EF = ejection fraction; ESV = end-systolic volume; PER =
peak ejection rate; PFR = peak filling rate; 51 = systolic index; SV = stroke volume; TD = durat ion of
diastole ; TP~R = time to peak ejection rate; TPFR = time to peak filling rate; T5 = duration of systole .
JACC Vol. 5. No.5
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was applied to measurements of end-systolic volume and
ejection fraction. Predictive accuracy was calculated as the
ratio of true positive to the sum of true positive and false
positive estimates .
Results
Hypertrophic cardiomyopathy versus control group
(Table 3). Patients with hypertrophic cardiomyopathy had
a smaller end-systolic volume and higher ejection fraction
than did control subjects. The peak ejection rate was normal
or higher, but the 95% confidence limit of normal range
was exceeded in only 22 (25~) of the patients. There were
no significant differences in peak fillihg rate between pa-
tients with hypertrophic cardiomyopathy and control sub-
jects. In patients with hypertrophic cardiomyopathy, the
peak filling rate normalized by end-diastolic volume and by
stroke volume exceeded the normal range in 18 (20%) and
10 (II %), respectively, and was below normal in 3 (3%)
and 7 (8%), respectively . Time to peak ejection and systolic
index were similar in both groups, but patients with hy-
pertrophic cardiomyopathy showed a considerable prolon-
gation of the time to peak filling rate which exceeded the
normal range in 41 (47%) patients.
.Absolute peak ejection and filling rates of patients with
hypertrophic cardiomyopathy were correlated with end-di-
astolic volume and stroke volume, but not with ejection
fraction (Table 4). The end-diastolic volume-normalized peak
rates of ejection and filling showed better correlation with
ejection fraction and inverse correlation with end-systolic
volume . The normalized peak ejection rate showed an in-
verse relation with time to peak ejection rate , but normalized
peak filling rate did not correlate with time to peak filling .
There was no correlation between any of the angiographic
indexes of left ventricular function and hemodynamic mea-
surements: right atrial , pulmonary capillary wedge or left
Table 4. Correlation of Indexes of Ventricular Ejection and Filling With Ventricular Volumes, Ejection Fraction and Time Intervals
in 88 Patients With Hypertrophic Cardiomyopathy
EDV ESV SV EF TS TPER
PER 0.74+ 0.13 0.81+ 0.22* -0.17 -0.08
PER/EDV -0.22* -O.4n -0.07 0.38+ - 0.39t - 0.44+
PERlSV -0.22* -0.05 -0.24* - 0.15 -0.49+ - 0.47+
PFR 0.65+ 0.16 0.68+ 0. 19
PFRlEDV -0.18 -0.3I t -0.07 0.36+
PFRISV
-0·13 -0.02 -0.14 0.11
*p < 0.05; tp < 0.01; +p < 0.001. The data represent correlation coefficients. Abbreviations as in Table 3.
TD
0.12
- 0.49*
-0.55t
TPFR
-0.04
-0.29t
-0.29t
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Table 5. Comparison of Left Ventricular Volumes. Peak Ejection and Filling Rates and Time
Intervals in Survivors Versus Patients Who Died Suddenly or of Other Cardiac Causes
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EDV (cc)
ESV (cc)
SV (cc)
EF (~)
PER (eels)
PER/EDV (liters/s)
PERISV (liters/s)
Pf'R (cc/s)
PFR/EDV (Iiters/s)
Pf'RISV (Iiters/s)
TS (ms)
TPER (rns)
51 (%)
TD (ms)
TPFR (rns)
Survivors (n " 67)
139 "- 42
24 -.- 12
115 +_ 39
82 "- 9
704 :!: 248
5.13 :':: 1.17
6.24 "!c 1.33
719 -'- 247
4.88 "!c 1.53
5.82 -'- 170
293 j- 51
146 :':: 54
49 -.- 16
462 .±: 157
183 ± 54
Patients Who
Died Suddenly
(n II)
148 -'- 76
28 ~ 41
120 :!: 57
85 :':: 14
631 -'- 253
4.57 -.- 0.95
5041 -.- 0.69'
605 :':: 255
4.02 "- 0.94'
4.75 :':: 1.08*
311 ::+- 56
144 -'- 76
46 -'- 21
558 :':: 141
179 :±. 48
Patients Who Died of
Other Cardiac
Causes (n = 10)
126 :±: 63
17 :':: II
109 :±: 55
86 "- l)
MO ::': 383
5.13 ± 1041
6.01 :!: 1.65
739 :':: 388
5.65 -.- 2.24
6.50 -'- 2.25
300 -.- 78
165 -.- 105
53 ± 22
412 :':: 138
202 -.- 47
'I' < 0.02 versus survivors. Abbreviations as in Table 3.
ventricular end-diastolic pressures or left ventricular pres-
sure gradient.
Survival (Table 5). Ventricular volumes and ejection
fraction were similar in survivors and patients who died.
Patients who died suddenly had lower peak ejection and
peak filling rates than did survivors. whereas the times to
peak ejection and to peak filling were similar. Of patients
who died suddenly, the young had a smaller end-systolic
volume and higher ejection fraction than did the older pa-
tients (Table 6); normalized indexes of ejection and filling
were lower in both groups than in the survivors. Patients
who died of other cardiac causes had similar peak rates of
ejection and tilling to those observed in the survivors.
Progressive symptoms (Table 7). Patients with pro-
gressive symptoms were older at diagnosis than those with-
out progressive symptoms (44 ± 14 versus 35 ± 14 years;
p = 0.0 I) and had shorter duration of follow-up study (5.8
± 4 versus 8.4 ± 5 years; p = 0.025). They had a higher
mean pulmonary capillary wedge pressure (20 ± 7 versus
15 ± 4 mm Hg: p = 0.0 I) and left ventricular end-diastolic
pressure (22 ± 8 versus 17 ± 6 mm Hg; p = 0.02). A
left ventricular gradient of 20 mm Hg or more at rest was
recorded in 13 (62%) of patients with progressive symptoms
and in 14 (23%) of those without progressive symptoms
(p < 0.(01). The magnitude of the gradient was also higher
in patients with progressive symptoms than in the remainder
Table 6. Comparison of Left Ventricular Volumes and Normalized Peak Ejection and Filling
Rates in Young and Older Patients Who Died Suddenly Versus Survivors
Patients Who Died Suddenly
Young (n = 5) Older (n = 6) Survivors (n = 67)
EDV (cc) 120 .. 50 171 .±: 90 139 + 42
ESV (cc) IO.±: 7t 42 -.- 53 24 .±: 12
EF (cit) 92 -.- 5* 79 "- 17 82 -.- 9
PER/EDV (liters/s) 4.83 ± O.M 4.36 ± 1.16 5.13 j- 1.17
PERlSV (Iiters/s) 5.28 ± 0.65* 5.52 ± 0.77 6.24 ± U3
Pf'R/EDV (liters/s) 4041 -.- un 3.69 .±: 0.76t 4.88 + 1.53
PFRISV (Iiters/s) 4.77 . 0.96 4.73 ± 1.26 5.82 -'- 1.70
*1' < 0.05 versus survivors; tp < 0.01. Abbreviations as in Table 3.
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Table 7. Comparison of Left Ventricular Volumes, Peak Ejection and Filling Rates and Time
Intervals in Patients With and Without Progressive Symptoms
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EOV (cc)
ESV (cc)
SV (cc)
EF(%)
PER (cc/s)
PER/EOV (Iiters/s)
PER/SV (liters/s)
PFR (cc/s)
PFRlEOV (Iiters/s)
PFR/SV (liters/s)
TS (ms)
TPER (ms)
SI (%)
TO (ms)
TPFR (ms)
Patients With Progressive
Symptoms (n = 2 I)
142 ± 55
19 ± 10
123 ± 47
87 ± 4
726 ± 311
5.12 ± 1.12
5.89 ± 1.32
744 ± 265
5.04 ± 1.27
5.76 ± 1.48
31 I ± 58
162 ± 81
51 ± 19
481 ± 133
182 ± 50
Patients Without Progressive
Symptoms (n = 67)
137 ± 40
25 ± 20
112 ± 41
82 ± 10*
676 ± 249
5.04 ± 1.20
6.18 ± 1.33
696 ± 268
4.81 ± 1.69
5.76 ± 1.03
290 ± 53
143 ± 57
49 ± 18
466 ± 164
187 ± 55
*p < 0.002. Abbreviations as in Table 3.
(mean 55 ± 50 versus 18 ± 32 mm Hg; p = 0.004).
Patients with progressive symptoms had a higher ejection
fraction (p = 0.002), but other angiographic indexes and
time intervals were similar to those of patients without pro-
gressive symptoms.
Ventricular tachycardia (Table 8). Patients with ven-
tricular tachycardia had a higher peak ejection rate than did
those without ventricular tachycardia (p = 0.015); however,
the differences in normalized peak ejection rate and in ab-
solute and normalized peak filling rates were not significant.
Patients with ventricular tachycardia had a significantly shorter
time to peak ejection rate and a prolonged time to peak
filling rate compared with those without ventricular tachy-
cardia. Among patients with ventricular tachycardia, the 4
who died suddenly had lower indexes of ejection than did
the 10 survivors (peak ejection rate normalized by end-
Table 8. Comparison of Left Ventricular Volumes, Peak Ejection and Filling Rates and Time
Intervals in Patients With and Without Ventricular Tachycardia
EOV (cc)
ESV (cc)
SV (cc)
EF (%)
PER (cc/s)
PER/EOV (Iiters/s)
PER/SV (Iiters/s)
PFR (cc/s)
PFRlEOV (Iiters/s)
PFR/SV (Iiters/s)
TS (ms)
TPER (ms)
SI (%)
TO (ms)
TPFR (ms)
Patients With VT (n = 14)
170 ± 58
33 ± 34
137 ± 45
82 ± II
864 ± 226*
5.38 ± 1.47
6.52 ± 1.45
745 ± 284
4.28 ± 1.20
5.22 ± 1.40
292 ± 64
122 ± 55*
41 ± 15*
511 ± 133
213 ± 60*
Patients Without VT (n = 43)
141 ± 38
25 ± 13
115 ± 35
82 ± 10
679 ± 233
4.86 ± 1.10
5.99 ± 1.32
704 ± 222
4.72 ± 1.45
5.67 ± 1.63
300 ± 53
156 ± 62
52 ± 17
467 ± 148
184 ± 53
*p < 0.05. VT = ventricular tachycardia; other abbreviations as in Table I.
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diastolic volume: 4.01 ± 1.2 versus 5.93 ± 1.2 S-I, P =
0.04; and normalized by stroke volume: 5.13 ± 0.71 versus
7.07 ± 1.3 S-I, P = 0.005) (Fig. 3A). The differences in
peak filling rates between the 4 who died suddenly and the
10 who survived were not significant (peak filling rate nor-
malized by end-diastolic volume: 3.82 ± 0.93 versus 4.46
± 1.29 s I, respectively;and normalizedby stroke volume:
5.01 ± 1.24 versus 5.30 ± 1.51 S-I, respectively) (Fig.
38). The mean duration of follow-up study in the 4 patients
with ventricular tachycardia who died suddenly was similar
to that of the 10 who survived (10 ± 7 versus 9 ± 5 years).
Figure 3. Normalized indexes of ventricular ejection and tilling
in IO patients with ventricular tachycardia (VT) who survived and
4 who died suddenly, compared with all II patients who died
suddenly andwith 67survivors. A. Peak ejection rates normalized
by end-diastolic volume (PER/EDV) were higher in patients with
ventricular tachycardia who survived than in those who died sud-
denly. 8, Peak tilling rates normalized by end-diastolic volume
(PFR/EDV) were higher in thesurvivors than in patients who died
suddenly.
Prediction of sudden death, progressive symptoms and
ventricular tachycardia (Table 9). Clinical features had
low accuracy for predicting sudden death (23%). Angio-
graphic measurements alone were slightly more accurate
with fewer false negative (18%) and false positive estimates
(28%). Sudden death was best predicted by a combination
of five clinical features and angiographic measurements:
large end-diastolic volume, small end-systolic volume, low
peak filling rate, atrial fibrillation at diagnosis and increased
R wave amplitude in lead aVL.
Ventricular tachycardia was predicted with similar ac-
curacy by clinical features (46%) and angiographic mea-
surements (44%). When clinical and angiographic variables
were combined, the predictive accuracy for ventricular
tachycardia was improved (67%).
Progressive symptoms were best predicted by clinical
and hemodynamic variables; the predictive accuracy was
not improved by the addition of angiographic measure-
ments. Of these, high ejection fraction alone best predicted
progressive symptoms.
A. Systole.
B. Diastole.
sudden
death
N = 11
p =0.04
p = 0.02
Discussion
Evaluation of left ventricular function. Peak rates of
ejection and filling derived from digitized left ventricular
cineangiograms have been validated by direct measurements
of aortic blood flow both in patients with hypertrophic car-
diomyopathy and in patients with other cardiac states
(18,19,22). Our findings of normal or hyperkinetic systolic
function and impaired diastolic function confirm previous
reports (20-24). In this study, hyperkinetic systolic function
was indicated by high peak ejection rate, short time to peak
ejection rate, high left ventricularejection fraction and small
end-systolic volume. There was no correlation between peak
ejection rate and time to peak ejection rate, ejection fraction
or end-systolic volume (Table 4), and therefore peak ejec-
tion rate was regarded as an independent index of systolic
function.
Prolonged time to peak filling rate was the most common
diastolic abnormality and was evident in nearly half of the
patients. The peak filling rate was normal in the majority
and this is consistent with previous angiographic (23), radio-
nuclide(21) and echocardiographicstudies (20,25), but con-
trasts with two echocardiographic reports (26,27) of de-
creased ventricular filling rates. The peak filling rate and
time to peak filling rate showed no correlation and, as re-
ported previously (21), both can be regarded as independent
indexes of diastolic function.
Absolute peak rates of ejection and filling were normal-
ized by both end-diastolic volume and stroke volume. The
absolute rates showed a strong correlation with end-diastolic
and stroke volumes, but no correlation withejection fraction.
Hammermeister et al. (18,19) made similar observations
alive
N = 67
alive
N = 67
VT +
sudden
death
N = 4
VT +
sudden
death
N = 4
VT
N = 10
VT
N = 10
p=O.OI
sudden
death
N = 11
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Table 9. Prediction of Sudden Death , Ventricular Tachycardia and Progressive Symptoms Using Clinical Features and
Angiographic Indexes
Pred ictive Accur acy
A. Predictors of Sudden Death
False Negative False Positive
Clinical: AP ." R wave in aVL "
Angiographic: EDV ," - ESV ," - PFR "
Cl inical and angiog raphic: ED V, " -ESV," - PPR," AF ," R wave in aV L"
B. Predictors of Ventr icular Tachycardi a
Clinical : progressive symptoms ," synco pe ," SV 1 + RV, "
Angiographic : PER, " - sys to lic index .
Clinical and angiog raphic: progressive sy mptoms,t syncope. t
- time to PER .t time to PPR ," PER
C. Predictors of Progressive Symptoms
Clinical: AF. " pew," basal LVOT gradient"
Angiographic: EF*
23%
32%
43 %
46 %
44 %
67%
46%
38%
27%
18%
18%
21%
2 1%
0%
19%
24%
39%
28%
18%
30%
32%
16%
25%
39%
*p < 0. 05; t p < O.lJO I; P value denotes the statistica l significance of individual determinants; minu s sign indicates nega tive co rre lation. AF = atr ial
fibrill at ion at diag nosis; ED V = end-diasto lic volum e; EF = ejec tion fraction; ESV = end-sys tolic volume ; LVOT = left ventricular outflow tract ;
pew = pulmonary capillary wedge pressure; PER = peak ejection rate : PFR = peak filling rate; SV I + RV, = sum of amplitudes of S wave in lead
V I and R wave in lead V, .
and sugge sted that normalized peak rates of ejection and
filling may be better indexes of ventricular function. In this
study, we evaluated both absolute and normalized rates of
ejection and filling in relation to prognosis . Normalized rates
were particul arly useful in establishing differences between
survivors and patients who died suddenly , whereas absolute
rates emerged from the stepwise discriminant analy sis as
measurements predictive of ventricular tachycardia and sud-
den death .
Predictors of sudden death. Ventricular volume and
ejection fraction were similar in survivors and patients who
died suddenly. However, patients who died suddenly had
lower peak rates of ejection and filling. The differences were
significant for normalized indexes that had a narrower range
of values than the absolute peak rates of eject ion and filling.
The indexes of systolic and diastolic function were de-
creased irrespective of patient age or severity of symptoms
at diagnosis.
The combination of atrial fibrillation at diagnosis and
increased R wave amplitude in lead aVL were the clinical
features that best predicted sudden death ; their predictive
accuracy was low (23%). In a previous retrospective anal-
ysis of 254 patients (9), the combination of young age at
diagnosis, syncope and family history of hypertrophic car-
diomyopathy and sudden death were shown to be the best
predictors of sudden death. In that study, II of 27 ch ildren
(aged 14 years or younger at diagnosis) died suddenly and
had a significantly greater incidence of syncope and sudden
death in family members compared with the survivors. Only
I of the II who died suddenly had a left ventricular ang io-
gram that was suitable for digitization . The relative exclu-
sion of these children may account for the different cl inical
feature s that were found to be predictive of sudden death
in the current analysis .
The combination of three angiographic indexes , in-
creased end-diastolic volume , small end-systolic volume
and low peak filling rate , showed a slightly better pred ictive
accurac y for sudden death (32%) than that of clinical fea-
tures in either the current study (23%) or a previous study
(24%) (9) . Sudden death was best predicted by the com-
bination of angiographic measurements and clinical features
(predictive accuracy 43%).
Role of ventricular tachycardia. Serious ventricular
arrhythmias are common in hypertrophic cardiomyopathy
(7,8,10.28-30), and ventricular tachycardia occurs in up to
25% of patients (8,30,3 1). Although ventr icular tachycardia
has been clearl y associated with sudden death (8,30), some
patient s survive despite repeated documented episodes. Our
result s suggest that impaired left ventri cular function may
be an important predictor of which patients are at part icular
risk. All four patient s who had ventr icular tachycard ia and
impaired left ventricular function died suddenly, whereas
those with ventricular tachycardia who exhibited norm al or
"supernormal" left ventricular function survived .
Predictors of progressive symptoms. Patients who ex-
perienced progressive symptoms showed greater abnormal-
ities of hemodynamic measurements than did those with
unchanged or improved symptoms. The differences included
higher pulmonary capillary wedge and left ventricular end-
diastol ic pressures and a higher inciden ce and magnitude of
basal left ventricular outflow tract gradient in patients with
progressive symptoms . Of these variables, the increased
lACC Vol. 5, No.5
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pulmonary capillary wedge pressure and the magnitude of
left ventricular outflow tract gradient, together with atrial
fibrillation at diagnosis. were the combination of variables
that best predicted progression of symptoms. These findings
are consistent with the observation by Ciro et al. (31) of
progressive symptoms in those with increased left ventric-
ular gradients during follow-up study. The addition of an-
giographic indexes to clinical and hemodynamic features
did not improve the predictive accuracy for progressive
symptoms.
Clinical implications. The most important problem in
the management of patients with hypertrophic cardio-
myopathy is the risk of sudden death, Recent studies have
developed the clinical profile of those patients at greatest
risk. It is known that children. patients with syncope or
those with a family history of hypertrophic cardiomyopathy
and sudden death and those with ventricular tachycardia
during electrocardiographic monitoring are at particular risk
(8,9,11,12,30.32). Although these studies have not shown
a relation between the presence or magnitude of a left ven-
tricular pressure gradient or left ventricular end-diastolic
pressure and sudden death. more extensive evaluation of
left ventricular function in relation to prognosis has not been
performed, In this study, we have demonstrated that the
addition of angiographically derived indexes of left ven-
tricular function contributes to the clinical profile of the high
risk patient. In particular, patients with impaired systolic
and diastolic function at the time of diagnosis were at in-
creased risk.
In many instances in this study. left ventricular cinean-
giograms were performed for diagnostic purposes; with cur-
rent technology the two-dimensional echocardiogram is the
best available means of demonstrating unexplained left ven-
tricular hypertrophy, and it is seldom necessary to perform
cardiac catheterization and angiography for diagnostic pur-
poses. The strong correlation of contrast angiographic and
radionuclide angiographic indexes of left ventricular func-
tion suggests that this repeatable and reproducible nonin-
vasive technique may be appropriate for the assessment of
left ventricular function in these patients (33.34).
Unfortunately. the predictive power of the conventional
clinical, hemodynamic and angiographic features and mea-
surements that could be assessed in this study was poor
(43%), Future analyses that include the results of electro-
cardiographic monitoring, cross-sectional echocardio-
graphic measurements of the extent and distribution of left
ventricular hypertrophy and characterization of left ventric-
ular gradients in relation to mechanism may improve the
predictive accuracy for sudden death. Another important
determinant of sudden death must be the underlying elec-
trical stability of the myocardium, and at present we do not
have an appropriate method of assessing this factor in pa-
tients with hypertrophic cardiomyopathy.
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